Evidence map›Paper›PMID 19427900›Full record

ReviewCellular signalling2009

Proteoglycan signaling co-receptors: roles in cell adhesion, migration and invasion.

Karthikeyan Mythreye, Gerard C Blobe

Abstract readReview
In one paragraph

Review in Cellular signalling, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 147 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. A tumor-promoting role for soluble TβRIII in glioblastoma.Molecular and cellular biochemistry · 2021
    Article
  19. Review
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Karthikeyan MythreyeDepartment of Medicine, Duke University Medical Center, Durham, NC 27708, USA.
Gerard C Blobe
Duke University Hospital · US

Funding

Role of TbRIII in Regulating Motility and InvasionR01CA135006 · NCI · DUKE UNIVERSITY · PI BLOBE, GERARD C · 2009 to 2013
$2.2M
Function of TbRIII as a BMP Co-receptor in Human CancerR01CA136786 · NCI · DUKE UNIVERSITY · PI BLOBE, GERARD C · 2009 to 2013
$1.8M
TbetaRIII as a Mediator/Regulator of SignalingR01CA106307 · NCI · DUKE UNIVERSITY · PI BLOBE, GERARD C · 2005 to 2009
$1.6M
NCI NIH HHS R01 CA106307NCI NIH HHS R01 CA135006NCI NIH HHS R01 CA136786
6 · The paper itself

Abstract

Signaling co-receptors are diverse, multifunctional components of most major signaling pathways, with roles in mediating and regulating signaling in both physiological and pathophysiological circumstances. Many of these signaling co-receptors, including CD44, glypicans, neuropilins, syndecans and TssRIII/betaglycan are also proteoglycans. Like other co-receptors, these proteoglycan signaling co-receptors can bind multiple ligands, promoting the formation of receptor signaling complexes and regulating signaling at the cell surface. The proteoglycan signaling co-receptors can also function as structural molecules to regulate adhesion, cell migration, morphogenesis and differentiation. Through a balance of these signaling and structural roles, proteoglycan signaling co-receptors can have either tumor promoting or tumor suppressing functions. Defining the role and mechanism of action of these proteoglycan signaling co-receptors should enable more effective targeting of these co-receptors and their respective pathways for the treatment of human disease.

Indexed as

Cell AdhesionCell MovementHumansNeoplasm InvasivenessProteoglycansReceptors, Cell SurfaceSignal TransductionProteoglycansReceptors, Cell Surface

Identifiers

PMID19427900
PMCPMC2735586
OpenAlexW2063911241

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.